180 related articles for article (PubMed ID: 28463682)
1. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy.
Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM
Am J Pathol; 2017 Jul; 187(7):1577-1585. PubMed ID: 28463682
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy.
Boursereau R; Abou-Samra M; Lecompte S; Noel L; Brichard SM
BMC Biol; 2018 Mar; 16(1):33. PubMed ID: 29558930
[TBL] [Abstract][Full Text] [Related]
3. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
4. Involvement of adiponectin in the pathogenesis of dystrophinopathy.
Abou-Samra M; Lecompte S; Schakman O; Noel L; Many MC; Gailly P; Brichard SM
Skelet Muscle; 2015; 5():25. PubMed ID: 26257862
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.
Lecompte S; Abou-Samra M; Boursereau R; Noel L; Brichard SM
Cell Mol Life Sci; 2017 Jul; 74(13):2487-2501. PubMed ID: 28188344
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
8. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
11. Local induction of adiponectin reduces lipopolysaccharide-triggered skeletal muscle damage.
Jortay J; Senou M; Delaigle A; Noel L; Funahashi T; Maeda N; Many MC; Brichard SM
Endocrinology; 2010 Oct; 151(10):4840-51. PubMed ID: 20702578
[TBL] [Abstract][Full Text] [Related]
12. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
[TBL] [Abstract][Full Text] [Related]
13. Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.
Yin X; Tang Y; Li J; Dzuricky AT; Pu C; Fu F; Wang B
Muscle Nerve; 2017 Oct; 56(4):759-767. PubMed ID: 27997693
[TBL] [Abstract][Full Text] [Related]
14. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
15. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
Acharyya S; Villalta SA; Bakkar N; Bupha-Intr T; Janssen PM; Carathers M; Li ZW; Beg AA; Ghosh S; Sahenk Z; Weinstein M; Gardner KL; Rafael-Fortney JA; Karin M; Tidball JG; Baldwin AS; Guttridge DC
J Clin Invest; 2007 Apr; 117(4):889-901. PubMed ID: 17380205
[TBL] [Abstract][Full Text] [Related]
16. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
[TBL] [Abstract][Full Text] [Related]
17. New targets to alleviate skeletal muscle inflammation: role of microRNAs regulated by adiponectin.
Boursereau R; Abou-Samra M; Lecompte S; Noel L; Brichard SM
Sci Rep; 2017 Feb; 7():43437. PubMed ID: 28240307
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
[TBL] [Abstract][Full Text] [Related]
19. Duchenne muscular dystrophy progression induced by downhill running is accompanied by increased endomysial fibrosis and oxidative damage DNA in muscle of mdx mice.
Lazzarin MC; Dos Santos JF; Quintana HT; Pidone FAM; de Oliveira F
J Mol Histol; 2023 Feb; 54(1):41-54. PubMed ID: 36348131
[TBL] [Abstract][Full Text] [Related]
20. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
